Raskob, G. E. et al. Thrombosis: a major contributor to global disease burden. Arterioscler. Thromb. Vasc. Biol. 34, 2363–2371 (2014).
Article CAS PubMed Google Scholar
Wendelboe, A. M. & Raskob, G. E. Global burden of thrombosis. Circ. Res. 118, 1340–1347 (2016).
Article CAS PubMed Google Scholar
Heit, J. A. The epidemiology of venous thromboembolism in the community. Arterioscler. Thromb. Vasc. Biol. 28, 370–372 (2008).
Article CAS PubMed PubMed Central Google Scholar
Heit, J. A., Cohen, A. T. & Anderson, F. A. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. Blood 106, 910–910 (2005).
Cohen, A. T. et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb. Haemost. 98, 756–764 (2007).
Article CAS PubMed Google Scholar
Lehnert, P., Lange, T., Møller, C., Olsen, P. & Carlsen, J. Acute pulmonary embolism in a national danish cohort: increasing incidence and decreasing mortality. Thromb. Haemost. 118, 539–546 (2018).
Jiménez, D. et al. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. Int. J. Cardiol. 269, 327–333 (2018).
Konstantinides, S. V., Barco, S., Lankeit, M. & Meyer, G. Management of pulmonary embolism: an update. J. Am. Coll. Cardiol. 67, 976–990 (2016).
Jiménez, D. et al. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J. Am. Coll. Cardiol. 67, 162–170 (2016).
Keller, K. et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur. Heart J. 41, 522–529 (2020).
Mauritz, G.-J., Marcus, J. T., Westerhof, N., Postmus, P. E. & Vonk-Noordegraaf, A. Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart 97, 473–478 (2011).
Marcus, J. T. et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension. J. Am. Coll. Cardiol. 51, 750–757 (2008).
Begieneman, M. P. V. et al. Pulmonary embolism causes endomyocarditis in the human heart. Heart 94, 450–456 (2007).
McIntyre, K. M. & Sasahara, A. A. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am. J. Cardiol. 28, 288–294 (1971).
Article CAS PubMed Google Scholar
Smulders, Y. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc. Res. 48, 23–33 (2000).
Article CAS PubMed Google Scholar
Lankhaar, J.-W. et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 291, H1731–H1737 (2006).
Article CAS PubMed Google Scholar
Rogers, M. A. M. et al. Triggers of hospitalization for venous thromboembolism. Circulation 125, 2092–2099 (2012).
Article PubMed PubMed Central Google Scholar
Anderson, F. A. Jr & Spencer, F. A. Risk factors for venous thromboembolism. Circulation 107, I9–I16 (2003).
Ku, G. H. et al. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 113, 3911–3917 (2009).
Article CAS PubMed PubMed Central Google Scholar
Chew, H. K., Wun, T., Harvey, D., Zhou, H. & White, R. H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch. Intern. Med. 166, 458–464 (2006).
Timp, J. F., Braekkan, S. K., Versteeg, H. H. & Cannegieter, S. C. Epidemiology of cancer-associated venous thrombosis. Blood 122, 1712–1723 (2013).
Article CAS PubMed Google Scholar
Blom, J. W., Doggen, C. J. M., Osanto, S. & Rosendaal, F. R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. J. Am. Med. Assoc. 293, 715–722 (2005).
Gussoni, G. et al. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb. Res. 131, 24–30 (2013).
Article CAS PubMed Google Scholar
Blanco-Molina, A. et al. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry. Thromb. Haemost. 101, 478–482 (2009).
Article CAS PubMed Google Scholar
Blanco-Molina, A. et al. Venous thromboembolism during pregnancy, postpartum or during contraceptive use. Thromb. Haemost. 103, 306–311 (2010).
Article CAS PubMed Google Scholar
van Hylckama Vlieg, A. & Middeldorp, S. Hormone therapies and venous thromboembolism: where are we now? J. Thromb. Haemost. 9, 257–266 (2011).
Lidegaard, Ø., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E. & Løkkegaard, E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. Br. Med. J. 343, d6423 (2011).
de Bastos, M. et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst. Rev. 3, CD010813 (2014).
van Vlijmen, E. F. W., Wiewel-Verschueren, S., Monster, T. B. M. & Meijer, K. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis. J. Thromb. Haemost. 14, 1393–1403 (2016).
Konstantinides, S. V. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Heart J. 41, 543–603 (2020).
Hobohm, L. et al. Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis. Clin. Res. Cardiol. https://doi.org/10.1007/s00392-022-02077-0 (2022).
Article PubMed PubMed Central Google Scholar
Kahn, S. R. & de Wit, K. Pulmonary embolism. N. Eng. J. Med. 387, 45–57 (2022).
Germini, F. et al. Pulmonary embolism prevalence among emergency department cohorts: a systematic review and meta‐analysis by country of study. J. Thromb. Haemost. 19, 173–185 (2021).
Klok, F. A., Meyer, G. & Konstantinides, S. Management of intermediate-risk pulmonary embolism: uncertainties and challenges. Eur. J. Haematol. 95, 489–497 (2015).
Article CAS PubMed Google Scholar
Huisman, M. V. et al. Pulmonary embolism. Nat. Rev. Dis. Prim. 4, 18028 (2018).
Romano, K. R. et al. Vancouver general hospital pulmonary embolism response team (VGH PERT): initial three-year experience. Can. J. Anesth. 67, 1806–1813 (2020).
Myc, L. A. et al. Adoption of a dedicated multidisciplinary team is associated with improved survival in acute pulmonary embolism. Resp. Res. 21, 159 (2020).
Wiske, C. P. et al. Evaluating time to treatment and in-hospital outcomes of pulmonary embolism response teams. J. Vasc. Surg. Venous Lymph. Disord. 8, 717–724 (2020).
Carroll, B. J. et al. Changes in care for acute pulmonary embolism through a multidisciplinary pulmonary embolism response team. Am. J. Med. 133, 1313–1321.e6 (2020).
Article PubMed PubMed Central Google Scholar
Rosovsky, R. et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J. Thromb. Thrombolysis 47, 31–40 (2019).
Sanchez, O. et al. Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the Pulmonary Embolism International THrOmbolysis (PEITHO)−3 trial. Thromb. Heamost. 122, 857–866 (2022).
Klok, F. A. et al. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study. Am. Heart J. 251, 43–53 (2022).
留言 (0)